The management of patients with some conditions can be complicated, and as a result it may not be possible to fully discharge patients from hospital back to the care of their General Practitioner (GP). Therefore, a system of Shared Care encompassing primary and hospital out-patient care is appropriate. You can access the list below for those medicines that have an agreed Shared Care Protocol within Cardiff and Vale UHB.
Shared care supporting documents:
Consultant request letter to GP for shared care or near patient testing (NTP)
The following Shared Care Protocols are organised by generic drug name.
| Protocol Number | Drug |
Indication |
| CV44 | Amiodarone | Severe cardiac rhythm disorders |
| CV02 | Apomorphine | Disabling Motor Fluctuations in Parkinson’s Disease |
| CV46 | Atomoxetine | Attention Deficit Hyperactivity Disorder (ADHD), Hyperkinetic Disorder (HKD) in children 6 years and older, adolescents and adults |
| CV51 | Azathioprine | Auto-immune conditions, usually when corticosteroid therapy alone provides inadequate control |
| CV04 | Azathioprine | Liver transplantation in adults |
| CV26 | Ciclosporin | Severe psoriasis |
| CV29 | Ciclosporin (Neoral) | Rheumatoid arthritis |
| CV20 | Disulfiram | Maintenance of abstinence in alcohol dependence |
| CV38 | Dornase alfa | Cystic fibrosis |
| CV08 | Erythropoietin | Anaemia associated with chronic renal failure in children |
| CV10 | Ketamine | Pain in a palliative care setting not responding to opioids and adjuvant therapy |
| CV40 | Lanreotide (Somatuline Autogel) | Acromegaly, carcinoid Syndrome and other peptide hormone secreting tumours |
| CV11 | Leflunomide | Rheumatoid arthritis and psoriatic arthritis |
| CV22 | Leuprorelin | Precocious puberty in children |
| CV57 | Lisdexamfetamine | Attention deficit hyperactivity disorder (ADHD) in children aged 6 years of age and over |
| CV12 | Lithium | Prophylaxis of mania, bipolar disorder, recurrent depression |
| CV25 | 6MP ( 6-Mercaptopurine) | Inflammatory Bowel Disease |
| CV54 | Melatonin | For children and adolescents (up to and including 18 years) with significant sleep onset difficulties |
| CV14 | Methadone | Pain requiring methadone for control |
| CV55 | Methotrexate | Rheumatoid arthritis and various auto-immune conditions, usually when corticosteroid therapy alone provides inadequate control |
| CV42 | Methylphenidate | Attention Deficit Hyperactivity Disorder (ADHD), Hyperkinetic Disorder (HKD) |
| CV53 | Mycophenolate mofetil | Various conditions, which characteristically respond to immunosuppressive therapy |
| CV16 | Octreotide (Sandostatin) | Palliative care setting |
| CV33 | Octreotide LAR (Sandostatin LAR) | Acromegaly, Carcinoid Syndrome and other peptide hormone secreting tumours |
| CV17 | Penicillamine | Rheumatoid arthritis |
| CV39 | Riluzole | Amyotrophic Lateral Sclerosis (ALS) |
| CV19 | Sodium aurothiomalate (Myocrisin) | Rheumatoid arthritis |
| CV34 | Somatropin | Adult growth disorders |
| CV27 | Somatropin | Growth Hormone in children |
| CV41 | Sulfasalazine | Inflammatory Bowel Disease (Crohn’s and ulcerative colitis) |
| CV21 | Sulfasalazine | Rheumatoid arthritis |
| CV43 | Tacrolimus | Liver transplantation in adults |
| CV48 | Tobramycin | Chronic colonisation with pseudomonas aeruginosa in cystic fibrosis |
| CV23 | Triptorelin | Precocious puberty in children |
